Lecturer in Biomedical Science specialising in cardiovascular inflammation and deputy programme director of the BSc (Hons) Biomedical Science programme. I also teach on a number of other undergraduate and postgraduate programmes.
I completed my undergraduate and postgraduate studies at the University of Bradford, leaving with a PhD in Pharmacology in 2019. I then continued my research into cardiovascular inflammation in a postdoctoral research position at the University of Hull before taking on a Lecturer in Biomedical Science position in 2021. In Oct 2022, I became Deputy Programme Director of the Biomedical Science programme.
My PhD research was focused on the potential role for IL-6 trans-signalling in pulmonary arterial hypertension (PAH), and whether prostanoid induction of SOCS3 is sufficient to limit IL-6 signalling and thus, have a therapeutic benefit in PAH. Now, my research interests have broadened to consider the efficacy of other novel therapeutic targets in the treatment of cardiovascular disease.
Alongside this, I am also interested in pedagogical topics such as post-graduate student experience, undergraduate assessment and feedback, and undergraduate awarding gaps.
I am the module lead of two Biomedical Science programmes - Skills for Biomedical and Forensic Scientists and Biological Basis of Disease. I also contribute to teaching on the MSc. Biomedical Sciences, MSc Pharmacology and Drug Discovery, non-medical prescribing, and MBBS programmes.
View Gillian's publications on ORCID.
Durham, G. A., Williams, J. J. L., Nasim, M. T. and Palmer, T. M. (2019) Targeting SOCS Proteins to Control JAK-STAT Signalling in Disease. Trends Pharmacol Sci.
Fellow of Advance HE
Member of the Royal Society of Biology
Biochemical Society Ambassador
Vice Chancellor Outstanding Achievement Award (May 2019, University of Bradford)
Physiolution GmbH prize for Exceptional Leadership and Engagement (Oct 2018, School of Pharmacy and Medical Sciences, University of Bradford)